Literature DB >> 3949886

Evidence for involvement of more than one class of glycoprotein in cell interactions with fibronectin.

H Urushihara, K M Yamada.   

Abstract

The receptor mechanism by which cells attach to fibronectin has been investigated by a combined immunologic and electrophoretic approach. One particular antiserum directed against 3T3 cell plasma membranes was found to contain antibodies that blocked spreading of these murine cells on fibronectin but not on laminin or serum spreading factor (vitronectin). Proteolysis experiments confirmed that this cell line has calcium-protected polypeptides necessary for cell spreading on fibronectin. Consequently, protein antigens were fractionated according to size by SDS gel electrophoresis, and antigens that could block the inhibitory activity of the polyclonal antibody were identified. One class of blocking antigen appeared to correspond to the 140,000-dalton complexes favored by several laboratories as fibronectin receptor candidates, but a second class of 45,000 daltons was also apparent. This 45,000-dalton antigen was a major absorbing activity from 3T3 cell membranes and the predominant activity from L929 membranes. By isoelectric focusing and two-dimensional gel electrophoresis, it was found to exist as a set of isoelectric point variants with pK = 5.3 to 6.2. Our results indicate that current models postulating a simple, unimolecular receptor mechanism for fibronectin may be oversimplified and that fibronectin may instead interact with more than one protein receptor component on the fibroblast cell surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949886     DOI: 10.1002/jcp.1041260302

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV.

Authors:  B Bauvois
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

2.  Identification of a novel glycoprotein (AGp110) involved in interactions of rat liver parenchymal cells with fibronectin.

Authors:  S C Stamatoglou; R C Ge; G Mills; T D Butters; F Zaidi; R C Hughes
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

3.  Modulation of matrix adhesive responses of human neuroblastoma cells by neighboring sequences in the fibronectins.

Authors:  G Mugnai; K Lewandowska; B Carnemolla; L Zardi; L A Culp
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

4.  Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix.

Authors:  S Saunders; M Bernfield
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

5.  The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix.

Authors:  C S Chen; P Thiagarajan; S M Schwartz; J M Harlan; R L Heimark
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

6.  Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin.

Authors:  S L Rogers; P C Letourneau; B A Peterson; L T Furcht; J B McCarthy
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

7.  Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain.

Authors:  K Lewandowska; H U Choi; L C Rosenberg; L Zardi; L A Culp
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

8.  Identification of a Ca2(+)-dependent cell-cell adhesion molecule in endothelial cells.

Authors:  R L Heimark; M Degner; S M Schwartz
Journal:  J Cell Biol       Date:  1990-05       Impact factor: 10.539

9.  Induction of fibronectin matrix assembly in human fibrosarcoma cells by dexamethasone.

Authors:  P J McKeown-Longo; C A Etzler
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.